Pathogenic germ line variants in a prospective multicenter cohort of patients with multiple myeloma
Blood Neoplasia
.
2024 Oct 12;2(1):100045.
doi: 10.1016/j.bneo.2024.100045.
eCollection 2025 Feb.
Authors
Julia Erin Wiedmeier-Nutor
1
,
Michael A Golafshar
2
,
Katie L Kunze
2
,
Edward D Esplin
3
,
Robert L Nussbaum
3
,
Erik Jessen
4
,
Brandie Heald
3
,
A Keith Stewart
5
,
N Jewel Samadder
6
7
,
P Leif Bergsagel
1
7
,
Rafael Fonseca
1
7
Affiliations
1
Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ.
2
Division of Health Services Research, Mayo Clinic, Phoenix, AZ.
3
Invitae Corporation, San Francisco, CA.
4
Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN.
5
Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
6
Division of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, AZ.
7
Mayo Clinic Center for Individualized Medicine, Rochester, MN.
PMID:
40546721
PMCID:
PMC12182856
DOI:
10.1016/j.bneo.2024.100045
No abstract available